期刊文献+

基于Excel函数设计茶碱口服多剂量个体化给药方案 被引量:4

Design of Individualized Dosage Regimen of Multiple Oral Dosing Theophtlline Based on Excel Function
原文传递
导出
摘要 目的:建立一种简便的茶碱口服多剂量个体化给药方案。方法:根据药动学参数,基于Excel函数,以茶碱为例设计单室模型血管外多剂量给药方案。结果:输入患者的生理和病理特征、茶碱每次给药剂量、间隔周期、吸收速率常数、药物清除率、吸收分数、表观分布容积,可计算出任意一次给药后t时刻的血药浓度、达峰时间、最大稳态血药浓度、最低稳态血药浓度、蓄积系数、达坪分数、坪幅,以及小儿和老人给药剂量,可绘制出血药浓度-时间曲线。结论:所采用方法可设计茶碱个体化给药方案,且简单、可靠、直观。 OBJECTIVE: To establish a simple individualized dosage regimen of multiple oral dosing of Theophyllin. METHODS: Based on pharmacokinetic parameters, Excel function was used to design the dosage regimen of multiple oral dosing extravascular administration of one compartment model with Theophylline as an example. RESULTS: The following parameters such as plasma drug concentration at any time (t) since administration of Theophylline, peak time, maximum steady plasmadrug concentration, minimum steady plasmadrug concentration, accumulation coefficient, fluctuation percentage, fluctuation amplitude, and dosage for children and the old could be obtained and the concentration- time curves were able to be drawn from the input data including physical and pathological parameters, dosage (X0) of Theophylline, interval τ, absorption rate constant (Ka), drug clearance rate (CL), absorption fraction (F) and apparent volume of distribution (Vd) . CONCLUSION: The method adopted in our study is simple, reliable and intuitive, and it is applicable for the design of the individualized dosage regimen of Theophyllin.
出处 《中国药房》 CAS CSCD 北大核心 2009年第26期2073-2075,共3页 China Pharmacy
基金 广东省医院药学研究基金(默沙东基金)资助项目(2000709)
关键词 辅助设计 单室模型 茶碱 Excel Computer assisted design Onecompartment Theophylline Excel
  • 相关文献

参考文献7

二级参考文献20

  • 1李珍,陈刚.群体药动学研究中非线性混合效应模型法的评价和应用[J].国外医学(药学分册),1993,20(4):195-199. 被引量:8
  • 2马全华,刘绪琢,王美玲.三点法监测氨茶碱血药浓度求算药动学参数[J].中国药学杂志,1995,30(8):482-484. 被引量:1
  • 3EASON J,MARKOWE H L J.Aminophylline toxicity--how many hospital asthma deaths does it cause ?[J].Respiratory Medicine,1989,83(3):219-226.
  • 4RICK T.Theophylline dose[EB/OL].http://www.rxlist.com/cgi/generic/theosr-cp.htm,2004.
  • 5孙丽萍 蔡映云.微机在抗哮喘药物研究中的应用[A].见:李明华.哮喘病药物治疗学[M].北京:人民卫生出版社,2001.422-430.
  • 6周怀悟 孙伟民.临床计量医学[M].上海:上海医科大学出版社,1999.88-94.
  • 7曾衍霖.临床药代动力学中群体及个体参数的估算[J]中国临床药理学杂志,1986(01).
  • 8J. E. Bennett,J. C. Wakefield. A comparison of a bayesian population method with two methods as implemented in commercially available software[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(4):403~432
  • 9Pascal Girard,Lewis B. Sheiner,Helen Kastrissios,Terrence F. Blaschke. Do we need full compliance data for population pharmacokinetic analysis?[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(3):265~282
  • 10René Bruno,Nicole Vivier,Jean Claude Vergniol,Susan L. Phillips,Guy Montay,Lewis B. Sheiner. A population pharmacokinetic model for docetaxel (Taxotere?): Model building and validation[J] 1996,Journal of Pharmacokinetics and Biopharmaceutics(2):153~172

共引文献18

同被引文献38

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部